Zacks Investment Research lowered shares of Landauer, Inc. (NYSE:LDR) from a buy rating to a hold rating in a research report sent to investors on Thursday morning.

According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “

A number of other brokerages have also recently issued reports on LDR. BidaskClub raised Landauer from a sell rating to a hold rating in a research report on Tuesday, August 15th. Hilliard Lyons raised Landauer from an underperform rating to a neutral rating in a research report on Wednesday, September 6th.

Landauer (NYSE:LDR) opened at 68.10 on Thursday. The stock’s 50 day moving average is $59.69 and its 200-day moving average is $53.58. The firm has a market capitalization of $656.35 million, a PE ratio of 35.27 and a beta of 1.27. Landauer has a 52-week low of $41.00 and a 52-week high of $68.40.

Landauer (NYSE:LDR) last announced its earnings results on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.18. The firm had revenue of $39.89 million during the quarter. Landauer had a return on equity of 80.03% and a net margin of 12.09%. Equities analysts expect that Landauer will post $1.95 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/11/landauer-inc-ldr-rating-lowered-to-hold-at-zacks-investment-research.html.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be given a dividend of $0.275 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.10 dividend on an annualized basis and a yield of 1.62%. Landauer’s payout ratio is currently 56.99%.

Institutional investors have recently made changes to their positions in the business. Mason Street Advisors LLC boosted its position in Landauer by 7.2% during the first quarter. Mason Street Advisors LLC now owns 2,250 shares of the scientific and technical instruments company’s stock worth $110,000 after purchasing an additional 151 shares during the period. BNP Paribas Arbitrage SA boosted its position in shares of Landauer by 55.1% in the second quarter. BNP Paribas Arbitrage SA now owns 3,112 shares of the scientific and technical instruments company’s stock valued at $163,000 after acquiring an additional 1,106 shares during the period. Smith Asset Management Group LP bought a new stake in shares of Landauer in the second quarter valued at approximately $179,000. Louisiana State Employees Retirement System bought a new stake in shares of Landauer in the second quarter valued at approximately $204,000. Finally, OxFORD Asset Management LLP bought a new stake in shares of Landauer in the second quarter valued at approximately $218,000. 80.99% of the stock is owned by hedge funds and other institutional investors.

Landauer Company Profile

Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.

Get a free copy of the Zacks research report on Landauer (LDR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related stocks with our FREE daily email newsletter.